These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials. Qiu B; Cai Y; Wang D; Lin J; Fan Y J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3463-3472. PubMed ID: 30185398 [TBL] [Abstract][Full Text] [Related]
43. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up. Luani B; Markovic S; Krumsdorf U; Rottbauer W; Wöhrle J EuroIntervention; 2015 May; 11(1):85-91. PubMed ID: 25572024 [TBL] [Abstract][Full Text] [Related]
44. Percutaneous closure of patent foramen ovale: safe and effective but underutilized. Nietlispach F; Meier B Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):121-3. PubMed ID: 25556896 [TBL] [Abstract][Full Text] [Related]
47. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661 [TBL] [Abstract][Full Text] [Related]
48. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack. Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394 [TBL] [Abstract][Full Text] [Related]
49. Second device for a patent foramen ovale: life saver and psychotherapy. Meier B Catheter Cardiovasc Interv; 2010 Jul; 76(1):151-2. PubMed ID: 20578221 [No Abstract] [Full Text] [Related]
51. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL; N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286 [TBL] [Abstract][Full Text] [Related]
52. Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials. Riaz H; Khan MS; Schenone AL; Waheed AA; Khan AR; Krasuski RA Am Heart J; 2018 May; 199():44-50. PubMed ID: 29754665 [TBL] [Abstract][Full Text] [Related]
53. Patent foramen ovale and cryptogenic stroke: the hole story. Furlan AJ; Jauss M Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069 [TBL] [Abstract][Full Text] [Related]
54. Secondary prevention of ischaemic stroke. Muller C; Roizman M; Wong A Intern Med J; 2019 Oct; 49(10):1221-1228. PubMed ID: 31602772 [TBL] [Abstract][Full Text] [Related]